Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Development of a central nervous system axonal myelination assay for high throughput screening.
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
Systematic Review of the Economics of Multiple Sclerosis in Latin America.
Multiple sclerosis disease-modifying therapy and pregnancy.
Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
The molecular basis of nutritional intervention in multiple sclerosis: a narrative review.
Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US.
The enigma of ceramide synthase regulation in mammalian cells.
Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis.
Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Vitamin D and autoimmunity.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.
Myelin Sheath Development in the Maxillary Nerve of the Newborn Pig.
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.
Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.
Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »